Latest Going Concern News

Xingye Gold (Hong Kong) Mining Company Limited has launched an off-market takeover offer for all remaining shares in Far East Gold Ltd (ASX:FEG) at $0.13 cash per share, offering shareholders a premium amid stalled projects and funding concerns.

Metro Performance Glass has significantly improved its financial footing in FY26, cutting net debt by more than half and boosting EBITDA before significant items to $18.2 million despite subdued markets in New Zealand and Australia.

5E Advanced Materials has requested suspension of its shares from ASX trading to enable its removal from the official list, marking a significant shift in its market presence.

Laramide Resources posted a CAD 1.13 million net loss for Q1 2026, reflecting ongoing exploration costs and a one-off loss from exiting its Kazakhstan asset. The company’s mineral property base expanded to CAD 118.7 million, driven by Australian and US projects.

AVITA Medical reported a 4% revenue increase in Q1 2026 with a narrowed net loss, underpinned by a new BARDA contract and promising Cohealyx clinical data. Leadership changes and regulatory approvals support a confident outlook.

5E Advanced Materials secures a decade-long boric acid offtake agreement and advances boron product development, while reporting a $12.1 million quarterly loss and planning ASX delisting.

EBR Systems accelerated its U.S. commercial rollout of the WiSE CRT System in Q1 2026 with implant volumes more than doubling and revenue hitting US$2.4 million. The company also secured a key regulatory milestone in Australia with TGA Priority Review, yet losses deepened and cash burn intensified, raising fresh questions about its funding runway.

Green Technology Metals (ASX: GT1) has initiated a fully underwritten $4 million entitlement offer to fund the next phase of its Seymour Lithium Project, alongside a $7 million placement subject to shareholder approval.

Critical Resources Limited (ASX:CRR) has initiated a pro-rata entitlement offer of Loyalty Options priced at $0.001 each, aiming to raise $319,410 and potentially $2.56 million upon exercise. The offer underscores significant dilution and operational risks amid ongoing exploration and legal challenges.

The Hydration Pharmaceuticals Company Limited (ASX: HPC) temporarily halted trading to relodge its FY25 Annual Report, revealing a $2.86 million loss driven by US market rationalisation and ongoing cost-cutting.

Multistack International reversed a $1.68 million loss to report a $2.26 million profit in 2025, driven by $4 million in settlement and asset disposal income. The company plans to exit its loss-making Australian operations through a share disposal while exploring new business avenues.

FBR Limited secured its first overseas Mantis welding robot sale, launched the Firehawk refractory robot, and expanded its Wall as a Service footprint in Victoria, while navigating a cash balance under $700,000.